Cover Image
市場調查報告書

Thelial Technologies S.A. - 產品平台分析

Thelial Technologies S.A. - Product Pipeline Review - 2016

出版商 Global Markets Direct 商品編碼 355513
出版日期 內容資訊 英文 26 Pages
訂單完成後即時交付
價格
Back to Top
Thelial Technologies S.A. - 產品平台分析 Thelial Technologies S.A. - Product Pipeline Review - 2016
出版日期: 2016年02月29日 內容資訊: 英文 26 Pages
簡介

Thelial Technologies S.A.總公司位於葡萄牙,正在進行極性修飾化合物的藥物研發及開發。提供利用具有專利的基於蠅胚之技術之癌症治療藥候補化合物,抗生劑,合成抗發炎劑,有機金屬的抗發炎劑,皮膚疾病治療藥等藥物候補之廣泛的化合物。

本報告提供Thelial Technologies S.A.的治療藥開發平台的現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Thelial Technologies S.A. 的基本資料

  • Thelial Technologies S.A. 概要
  • 主要資訊
  • 企業資料

Thelial Technologies S.A. :R&D概要

  • 主要的治療範圍

Thelial Technologies S.A. :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Thelial Technologies S.A. :開發中產品概況

  • 初期階段的開發中產品
    • 藥物研發階段的產品/聯合治療模式
  • 臨床階段不明的開發中產品
    • 臨床階段不明的產品/聯合治療模式

Thelial Technologies S.A. :藥物簡介

Thelial Technologies S.A. :開發平台分析

  • 各給藥途徑
  • 各分子類型

Thelial Technologies S.A. :總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

目錄
Product Code: GMDHC07980CDB

Summary

Global Markets Direct's, 'Thelial Technologies S.A. - Product Pipeline Review - 2016', provides an overview of the Thelial Technologies S.A.'s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Thelial Technologies S.A., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Thelial Technologies S.A.
  • The report provides overview of Thelial Technologies S.A. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Thelial Technologies S.A.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Thelial Technologies S.A.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

  • Evaluate Thelial Technologies S.A.'s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Thelial Technologies S.A.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Thelial Technologies S.A.'s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Thelial Technologies S.A. Snapshot
    • Thelial Technologies S.A. Overview
    • Key Information
    • Key Facts
  • Thelial Technologies S.A. - Research and Development Overview
    • Key Therapeutic Areas
  • Thelial Technologies S.A. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Thelial Technologies S.A. - Pipeline Products Glance
    • Thelial Technologies S.A. - Early Stage Pipeline Products
      • Discovery Products/Combination Treatment Modalities
    • Thelial Technologies S.A. - Unknown Stage Pipeline Products
      • Unknown Products/Combination Treatment Modalities
  • Thelial Technologies S.A. - Drug Profiles
    • The-103
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • The-104
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • The-105
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • The-106
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • The-107
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • The-108
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • The-109
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • The-110
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • The-111
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • The-124
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Thelial Technologies S.A. - Pipeline Analysis
  • Thelial Technologies S.A. - Pipeline Products by Route of Administration
  • Thelial Technologies S.A. - Pipeline Products by Molecule Type
  • Thelial Technologies S.A. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Thelial Technologies S.A., Key Information
  • Thelial Technologies S.A., Key Facts
  • Thelial Technologies S.A. - Pipeline by Indication, 2016
  • Thelial Technologies S.A. - Pipeline by Stage of Development, 2016
  • Thelial Technologies S.A. - Monotherapy Products in Pipeline, 2016
  • Thelial Technologies S.A. - Discovery, 2016
  • Thelial Technologies S.A. - Unknown, 2016
  • Thelial Technologies S.A. - Pipeline by Route of Administration, 2016
  • Thelial Technologies S.A. - Pipeline by Molecule Type, 2016

List of Figures

  • Thelial Technologies S.A. - Pipeline by Indication, 2016
  • Thelial Technologies S.A. - Pipeline by Stage of Development, 2016
  • Thelial Technologies S.A. - Monotherapy Products in Pipeline, 2016
  • Thelial Technologies S.A. - Pipeline by Molecule Type, 2016
Back to Top